Prevention by l-carnitine of DNA damage induced by propionic and l-methylmalonic acids in human peripheral leukocytes in vitro

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 702, Issue 1, 2010, Pages 123-128

  Ribas, Graziela S ^a,b   Manfredini, Vanusa ^c   de Marco, Maria Gilda ^c   Vieira, Rosana B ^c   Wayhs, Carlos Y ^a,b   Vanzin, Camila S ^a,b   Biancini, Giovana B ^a,b   Wajner, Moacir ^a,b   Vargas, Carmen R ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c DEPARTMENT OF FOOD ENGINEERING   (Brazil)

Author keywords

DNA damage; L Carnitine; Methylmalonic acid; Propionic acid

Indexed keywords

AMINO ACID; CARNITINE; ISOLEUCINE; METHIONINE; METHYLMALONIC ACID; PROPIONIC ACID; THREONINE; VALINE;

ARTICLE; COMET ASSAY; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID OXIDATION; METABOLIC DISORDER; METHYLMALONIC ACIDEMIA; NEUROLOGIC DISEASE; OXIDATIVE DEHYDROGENATION; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; PROTEIN RESTRICTION; SCORING SYSTEM; SILVER STAINING;

CARNITINE; COMET ASSAY; DNA DAMAGE; HUMANS; LEUKOCYTES; METHYLMALONIC ACID; MUTAGENS; PROPIONIC ACIDS;

EID: 77956442345     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.07.008     Document Type: Article

References (42)

1. Fenton W.A., Gravel R.A., Rosenblatt D.S. Disorders of propionate and methylmalonate metabolism. The Metabolic and Molecular Bases of Inherited Disease 2001, 2165-2194. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Deodato F., Boenzi S., Santorelli F.M., Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J. Med. Genet. C: Semin. Med. Genet. 2006, 142C:104-112.
3. Van Gosen L. Organic acidemias: a methylmalonic and propionic focus. J. Pediatr. Nurs. 2008, 23:225-233.
4. Saad L.O., Mirandola S.R., Maciel E.N., Castilho R.F. Lactate dehydrogenase activity is inhibited by methylmalonate in vitro. Neurochem. Res. 2006, 31:541-548.
5. Hoffmann G.F., Meier-Augenstein W., Stöckler S., Surtees R., Rating D., Nyhan W.L. Physiology and pathophysiology of organic acids in cerebrospinal fluid. J. Inherit. Metab. Dis. 1993, 16:648-669.
6. Wajner M., Dutra J.C., Cardoso S.E., Wannmacher C.M., Motta E.R. Effect of methylmalonate on in vitro lactate release and carbon dioxide production by brain of suckling rats. J. Inherit. Metab. Dis. 1992, 15:92-96.
7. Dutra J.C., Dutra-Filho C.S., Cardozo S.E., Wannmacher C.M., Sarkis J.J., Wajner M. Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J. Inherit. Metab. Dis. 1993, 16:147-153.
8. De Mello C.F., Begnini J., Jiménez-Bernal R.E., Rubin M.A., de Bastiani J., da Costa E., Wajner M. Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res. 1996, 721:120-125.
9. Fontella F.U., Pulrolnik V., Gassen E., Wannmacher C.M., Klein A.B., Wajner M., Dutra-Filho C.S. Propionic and l-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport 2000, 11:541-544.
10. Wyse A.T., Streck E.L., Barros S.V., Brusque A.M., Zugno A.L., Wajner M. Methylmalonate administration decreases Na+, K+-ATPase activity in cerebral cortex of rats. Neuroreport 2000, 11:2331-2334.
11. Brusque A.M., Borba Rosa R., Schuck P.F., Dalcin K.B., Ribeiro C.A., Silva C.G., Wannmacher C.M., Dutra-Filho C.S., Wyse A.T., Briones P., Wajner M. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 2002, 40:593-601.
12. Okun J.G., Hörster F., Farkas L.M., Feyh P., Hinz A., Sauer S., Hoffmann G.F., Unsicker K., Mayatepek E., Kölker S. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J. Biol. Chem. 2002, 277:14674-14680.
13. Schwab M.A., Sauer S.W., Okun J.G., Nijtmans L.G., Rodenburg R.J., van den Heuvel L.P., Dröse S., Brandt U., Hoffmann G.F., Ter Laak H., Kölker S., Smeitink J.A. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem. J. 2006, 398:107-112.
14. Yannicelli S. Nutrition therapy of organic acidaemias with amino acid-based formulas: emphasis on methylmalonic and propionic acidaemia. J. Inherit. Metab. Dis. 2006, 29:281-287.
15. Wajner M., Latini A., Wyse A.T., Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 2004, 27:427-448.
16. Sitta A., Barschak A.G., Deon M., de Mari J.F., Barden A.T., Vanzin C.S., Biancini G.B., Schwartz I.V., Wajner M., Vargas C.R. l-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol. Neurobiol. 2009, 29:211-218.
17. Barschak A.G., Sitta A., Deon M., de Oliveira M.H., Haeser A., Dutra-Filho C.S., Wajner M., Vargas C.R. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab. Brain Dis. 2006, 21:279-286.
18. Halliwell B., Gutteridge J.M.C. Oxidative stress: adaptation, damage, repair and death. Free Radicals in Biology and Medicine 2001, 246-350. Oxford University Press, Oxford. B. Halliwell, J.M.C. Gutteridge (Eds.).
19. Halliwell B. Role of free radicals in the neurodegenerative diseases. Drugs Aging 2001, 18:685-716.
20. Garcia C.L., Filippi S., Mosesso P., Calvani M., Nicolai R., Mosconi L., Palitti F. The protective effect of l-carnitine in peripheral blood human lymphocytes exposed to oxidative agents. Mutagenesis 2006, 21:21-27.
21. Fighera M.R., Bonini J.S., de Oliveira T.G., Frussa-Filho R., Rocha J.B., Dutra-Filho C.S., Rubin M.A., Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell Biol. 2003, 35:465-473.
22. Rigo F.K., Pasquetti L., Malfatti C.R., Fighera M.R., Coelho R.C., Petri C.Z., Mello C.F. Propionic acid induces convulsions and protein carbonylation in rats. Neurosci. Lett. 2006, 408:151-154.
23. Ribas G.S., Manfredini V., de Mari J.F., Wayhs C.Y., Vanzin C.S., Biancini G.B., Sitta A., Deon M., Wajner M., Vargas C.R. Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of l-carnitine supplementation. Int. J. Dev. Neurosci. 2010, 28:127-132.
24. Reznick A.Z., Kagan V.E., Ramsey R., Tsuchiya M., Khwaja S., Serbinova E.A., Packer L. Antiradical effects in l-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch. Biochem. Biophys. 1992, 296:394-401.
25. Muthuswamy A.D., Vedagiri K., Ganesan M., Chinnakannu P. Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: role of l-carnitine and dl-alpha-lipoic acid. Clin. Chim. Acta 2006, 368:84-92.
26. Gülçin I. Antioxidant and antiradical activities of l-carnitine. Life Sci. 2006, 78:803-811.
27. Derin N., Izgut-Uysal V.N., Agac A., Aliciguzel Y., Demir N. l-Carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J. Physiol. Pharmacol. 2004, 55:595-606.
28. Singh N., McCoy M., Tice R., Schneider E. A simple technique for quantification of low levels of DNA damage in individuals cells. Exp. Cell Res. 1988, 175:184-191.
29. Tice R.R., Agurell D., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
30. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith G., Speit G., Thybaud V., Tice R.R. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003, 18:45-51.
31. Liao W., McNutt M.A., Zhu W.G. The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 2009, 48:46-53.
32. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
33. Sirtori L.R., Dutra-Filho C.S., Fitarelli D., Sitta A., Haeser A., Barschak A.G., Wajner M., Coelho D.M., Llesuy S., Belló-Klein A., Giugliani R., Deon M., Vargas C.R. Oxidative stress in patients with phenylketonuria. Biochim. Biophys. Acta 2005, 1740:68-73.
34. D'Errico M., Parlanti E., Dogliotti E. Mechanism of oxidative DNA damage repair and relevance to human pathology. Mutat. Res. 2008, 659:4-14.
35. Altieri F., Grillo C., Maceroni M., Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid. Redox Signal. 2008, 10:891-937.
36. Indo H.P., Davidson M., Yen H.C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T., Majima H.J. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007, 7:106-118.
37. McLaughlin B.A., Nelson D., Silver I.A., Erecinska M., Chesselet M.F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience 1998, 86:279-290.
38. Markesbery W.R., Lovell M.A. DNA oxidation in Alzheimer's disease. Antioxid. Redox Signal. 2006, 8:2039-2045.
39. Augustyniak A., Skrzydlewska E. l-Carnitine in the lipid and protein protection against ethanol-induced oxidative stress. Alcohol 2009, 43:217-223.
40. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am. J. Kidney Dis. 2003, 41:S4-12.
41. Boerrigter M.E., Franceschi C., Arrigoni-Martelli E., Wei J.Y., Vijg J. The effect of l-carnitine and acetyl-l-carnitine on the disappearance of DNA single-strand breaks in human peripheral blood lymphocytes. Carcinogenesis 1993, 14:2131-2136.
42. Vanella A., Russo A., Acquaviva R., Campisi A., Di Giacomo C., Sorrenti V., Barcellona M.L. l-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol. Toxicol. 2000, 16:99-104.